Home › Hip Injuries and Disorders › NCT06024304
InterTAN: Integrated Dual Screw Design Improve Biomechanics/Function Following Fixation Surgery
Does an Integrated Dual Screw Design Improve Biomechanics and Function Following Fixation of Unstable Intertrochanteric Femur Fractures: A Randomized Pilot Trial (InterTAN)
Who can join
Ages 55 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * Non-pathologic fractures * OTA/AO classification 31A2, 31A3 fractures * Ability to participate in 4-MET equivalent activities without ambulatory assistance prior to injury Exclusion Criteria: * Inability to consent * Inability to participate in follow-up activities * History of chronic pain / current opioid treatment * Pre-injury ambulatory status requiring assistance device * Neurological condition altering gait or sensation (e.g. History of stroke with altered gait, peripheral neuropathy).
About the study
The goal of this pilot, patient blinded randomized trial is to develop a mechanistic understanding of gait following fixation of unstable intertrochanteric hip fractures and return to function and pain control. The guiding hypothesis that will be tested in a subsequent clinical trial is that the InterTAN when compared to standard lag-screw cephalomedullary nails will have decreased post operative pain, earlier return to symmetric weight bearing, and quicker return to pre-injury functioning levels.
What is being tested
- Synthes TFNA (device)
- Trigen InterTAN (device)
Sponsor: Paul E. Matuszewski · Participants: 30 · Started: Apr 18, 2025
Contact the study team
- Paul E Matuszewski, MD · Phone: (859) 323-5533
- Matthew Eubank · Phone: (859) 323-5533
Official record on ClinicalTrials.gov — NCT06024304
Locations in the U.S.
| Kentucky | University of Kentucky, Lexington |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.